Endurance: Aspen board has 'disdain' for shareholders
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • X
  • LinkedIn
  • Email
  • Free trial
  • Log in

Endurance: Aspen board has 'disdain' for shareholders

17 April 2014
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • X
  • LinkedIn
  • Email

Endurance has fought back against Aspen's adoption of a so-called 'poison pill' by accusing its fellow Bermudian's board of entrenching itself and showing "clear disdain" for shareholders.

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News M&A
Gift this article